**Core Concept**
The patient's hyperkalemia is likely due to a combination of factors, including his renal impairment (HIV nephropathy), excessive potassium intake through spironolactone, and possibly a drug interaction between trimethoprim-sulfamethoxazole and spironolactone. This complex interplay of factors necessitates a thorough understanding of renal physiology, electrolyte balance, and drug interactions.

**Why the Correct Answer is Right**
Spironolactone, a potassium-sparing diuretic, can cause hyperkalemia, especially in patients with renal impairment. The patient's HIV nephropathy already compromises his renal function, making it difficult for his kidneys to excrete potassium. Additionally, trimethoprim-sulfamethoxazole can increase the levels of potassium by inhibiting its secretion in the distal tubules and collecting ducts. This combination of factors likely contributed to the patient's hyperkalemia.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because while spironolactone can cause hyperkalemia, it is not the only contributing factor in this patient's case. The patient's renal impairment and potential drug interaction with trimethoprim-sulfamethoxazole also play a significant role.

**Option B:** This option is incorrect because the patient's HIV nephropathy, rather than his HIV infection itself, is the primary cause of his renal impairment. HIV infection can cause a range of renal complications, including HIV-associated nephropathy (HIVAN), but the patient's renal function is more directly affected by his HIVAN.

**Option C:** This option is incorrect because the patient's ascites and peripheral edema are more likely related to his alcoholic liver disease and cirrhosis, rather than his HIV infection or renal impairment.

**Option D:** This option is incorrect because while the patient's ECG changes, including peaking of the T-waves and QRS widening, are consistent with hyperkalemia, they are not the primary cause of his hyperkalemia.

**Clinical Pearl / High-Yield Fact**
In patients with renal impairment, potassium-sparing diuretics like spironolactone can cause significant hyperkalemia. It is essential to monitor potassium levels closely in these patients and adjust their medications accordingly.

**Correct Answer: C.**

✓ Correct Answer: B. Spironolactone, a commonly used diuretic for treating ascites in the setting of cirrhosis, acts as a competitive aldosterone inhibitor at the level of the collecting duct of the nephron, resulting in decreased potassium excretion and hyperkalemia.